{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T00:32:07Z","timestamp":1794702727695,"version":"4.9.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Viatris","id":[{"id":"https:\/\/ror.org\/01g1gvr46","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pain Ther"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s40122-026-00886-z","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T13:30:25Z","timestamp":1789219825000},"page":"1711-1730","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Improving Clinical Trial Design in Low Back Pain: Insights from Studies of Gabapentinoids"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9492-4698","authenticated-orcid":false,"given":"Ralf","family":"Baron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3759-1508","authenticated-orcid":false,"given":"Rainer","family":"Freynhagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6156-880X","authenticated-orcid":false,"given":"Bart","family":"Morlion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2630-7647","authenticated-orcid":false,"given":"Andrea","family":"Truini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9132-8965","authenticated-orcid":false,"given":"Chris","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4766-4807","authenticated-orcid":false,"given":"Sebnem","family":"Er","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7921-0849","authenticated-orcid":false,"given":"Gavin J.","family":"Lyndon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,9,12]]},"reference":[{"key":"886_CR1","doi-asserted-by":"publisher","unstructured":"Global, regional, and national burden of low back pain, 1990\u20132020, its attributable risk factors, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Rheumatol. 2023;5:e316\u201329. https:\/\/doi.org\/10.1016\/S2665-9913(23)00098-X.","DOI":"10.1016\/S2665-9913(23)00098-X"},{"key":"886_CR2","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1016\/S0140-6736(18)30725-6","volume":"391","author":"S Clark","year":"2018","unstructured":"Clark S, Horton R. Low back pain: a major global challenge. Lancet. 2018;391:2302. https:\/\/doi.org\/10.1016\/S0140-6736(18)30725-6.","journal-title":"Lancet"},{"key":"886_CR3","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1016\/S0140-6736(18)30488-4","volume":"391","author":"R Buchbinder","year":"2018","unstructured":"Buchbinder R, van Tulder M, \u00d6berg B, et al. Low back pain: a call for action. Lancet. 2018;391:2384\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(18)30488-4.","journal-title":"Lancet"},{"key":"886_CR4","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1016\/j.drudis.2018.06.004","volume":"23","author":"JD Markman","year":"2018","unstructured":"Markman JD, Baron R, Gewandter JS. Why are there no drugs indicated for sciatica, the most common chronic neuropathic syndrome of all? Drug Discov Today. 2018;23:1904\u20139. https:\/\/doi.org\/10.1016\/j.drudis.2018.06.004.","journal-title":"Drug Discov Today"},{"key":"886_CR5","doi-asserted-by":"publisher","unstructured":"Schmid A, Tampin B, Baron R, et al. Recommendations for terminology and the identification of neuropathic pain in people with spine-related leg pain. Outcomes from the NeuPSIG working group. Pain. 2023. https:\/\/doi.org\/10.1097\/j.pain.0000000000002919","DOI":"10.1097\/j.pain.0000000000002919"},{"key":"886_CR6","doi-asserted-by":"publisher","unstructured":"Cashin AG, Furlong BM, Kamper SJ, et al. Analgesic effects of non-surgical and non-interventional treatments for low back pain: a systematic review and meta-analysis of placebo-controlled randomised trials. BMJ Evid Based Med. 2025. https:\/\/doi.org\/10.1136\/bmjebm-2024-112974.","DOI":"10.1136\/bmjebm-2024-112974"},{"key":"886_CR7","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1007\/s40265-024-02085-6","volume":"84","author":"J Ward","year":"2024","unstructured":"Ward J, Grinstead A, Kemp A, Kersten P, Schmid AB, Ridehalgh C. A meta-analysis exploring the efficacy of neuropathic pain medication for low back pain or spine-related leg pain: is efficacy dependent on the presence of neuropathic pain? Drugs. 2024;84:1603\u201336. https:\/\/doi.org\/10.1007\/s40265-024-02085-6.","journal-title":"Drugs"},{"key":"886_CR8","unstructured":"IASP Terminology [Internet]. [cited 2026 July 13]. https:\/\/www.iasp-pain.org\/resources\/terminology\/. Accessed 13 July 2026."},{"key":"886_CR9","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1080\/03007995.2018.1552042","volume":"35","author":"R Freynhagen","year":"2019","unstructured":"Freynhagen R, Parada HA, Calderon-Ospina CA, et al. Current understanding of the mixed pain concept: a brief narrative review. Curr Med Res Opin. 2019;35:1011\u20138. https:\/\/doi.org\/10.1080\/03007995.2018.1552042.","journal-title":"Curr Med Res Opin"},{"key":"886_CR10","unstructured":"European medicines agency: lyrica public assessment report [Internet]. [cited 2026 July 13]. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/lyrica. Accessed 13 July 2026."},{"key":"886_CR11","unstructured":"Neurontin (gabapentin) Summary of Product Characteristics."},{"key":"886_CR12","unstructured":"Lyrica FDA Prescribing Information [Internet]. [cited 2026 July 13]. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/021446s046,022488s022lbl.pdf. Accessed 13 July 2026."},{"key":"886_CR13","doi-asserted-by":"publisher","unstructured":"Lin C-WC, Verwoerd AJH, Maher CG, et al. How is radiating leg pain defined in randomized controlled trials of conservative treatments in primary care? A systematic review. Eur J Pain. 2014;18:455\u201364. https:\/\/doi.org\/10.1002\/j.1532-2149.2013.00384.x.","DOI":"10.1002\/j.1532-2149.2013.00384.x"},{"key":"886_CR14","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.spinee.2017.05.005","volume":"17","author":"S Genevay","year":"2017","unstructured":"Genevay S, Courvoisier DS, Konstantinou K, et al. Clinical classification criteria for radicular pain caused by lumbar disc herniation: the radicular pain caused by disc herniation (RAPIDH) criteria. Spine J. 2017;17:1464\u201371. https:\/\/doi.org\/10.1016\/j.spinee.2017.05.005.","journal-title":"Spine J"},{"key":"886_CR15","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.spinee.2017.10.003","volume":"18","author":"S Genevay","year":"2018","unstructured":"Genevay S, Courvoisier DS, Konstantinou K, et al. Clinical classification criteria for neurogenic claudication caused by lumbar spinal stenosis. The N-CLASS Criteria. Spine J. 2018;18:941\u20137. https:\/\/doi.org\/10.1016\/j.spinee.2017.10.003.","journal-title":"Spine J"},{"key":"886_CR16","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pain.2009.08.020","volume":"147","author":"N Bogduk","year":"2009","unstructured":"Bogduk N. On the definitions and physiology of back pain, referred pain, and radicular pain. Pain. 2009;147:17\u20139. https:\/\/doi.org\/10.1016\/j.pain.2009.08.020.","journal-title":"Pain"},{"key":"886_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.aprim.2021.102144","volume":"54","author":"MS Gim\u00e9nez-Campos","year":"2022","unstructured":"Gim\u00e9nez-Campos MS, Pimenta-Fermisson-Ramos P, D\u00edaz-Cambronero JI, Carbonell-Sanch\u00eds R, L\u00f3pez-Briz E, Ru\u00edz-Garc\u00eda V. A systematic review and meta-analysis of the effectiveness and adverse events of gabapentin and pregabalin for sciatica pain. Aten Primaria. 2022;54:102144. https:\/\/doi.org\/10.1016\/j.aprim.2021.102144.","journal-title":"Aten Primaria"},{"key":"886_CR18","doi-asserted-by":"publisher","DOI":"10.5387\/fms.2013-22","author":"N Takahashi","year":"2014","unstructured":"Takahashi N, Arai I, Kayama S, et al. Therapeutic efficacy of pregabalin in patients with leg symptoms due to lumbar spinal stenosis. Fukushima J Med Sci. 2014. https:\/\/doi.org\/10.5387\/fms.2013-22.","journal-title":"Fukushima J Med Sci"},{"key":"886_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h1748","author":"SP Cohen","year":"2015","unstructured":"Cohen SP, Hanling S, Bicket MC, et al. Epidural steroid injections compared with gabapentin for lumbosacral radicular pain: multicenter randomized double blind comparative efficacy study. BMJ. 2015. https:\/\/doi.org\/10.1136\/bmj.h1748.","journal-title":"BMJ"},{"key":"886_CR20","doi-asserted-by":"publisher","unstructured":"Wang X, Martin G, Sadeghirad B, et al. Common interventional procedures for chronic non-cancer spine pain: a systematic review and network meta-analysis of randomised trials. Br Med J Publ Group. 2025 [cited 2026 July 10]. https:\/\/doi.org\/10.1136\/bmj-2024-079971.","DOI":"10.1136\/bmj-2024-079971"},{"key":"886_CR21","doi-asserted-by":"publisher","first-page":"e178","DOI":"10.1016\/S2665-9913(23)00324-7","volume":"6","author":"J Nijs","year":"2024","unstructured":"Nijs J, Kosek E, Chiarotto A, et al. Nociceptive, neuropathic, or nociplastic low back pain? The low back pain phenotyping (BACPAP) consortium\u2019s international and multidisciplinary consensus recommendations. Lancet Rheumatol. 2024;6:e178\u201388. https:\/\/doi.org\/10.1016\/S2665-9913(23)00324-7.","journal-title":"Lancet Rheumatol"},{"key":"886_CR22","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1212\/WNL.0000000000001168","volume":"84","author":"JD Markman","year":"2015","unstructured":"Markman JD, Frazer ME, Rast SA, et al. Double-blind, randomized, controlled, crossover trial of pregabalin for neurogenic claudication. Neurology. 2015;84:265\u201372. https:\/\/doi.org\/10.1212\/WNL.0000000000001168.","journal-title":"Neurology"},{"key":"886_CR23","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/papr.12470","volume":"17","author":"P H\u00fcllemann","year":"2017","unstructured":"H\u00fcllemann P, Keller T, Kabelitz M, Freynhagen R, T\u00f6lle T, Baron R. Pain drawings improve subgrouping of low back pain patients. Pain Pract. 2017;17:293\u2013304. https:\/\/doi.org\/10.1111\/papr.12470.","journal-title":"Pain Pract"},{"key":"886_CR24","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1111\/papr.12704","volume":"18","author":"P H\u00fcllemann","year":"2018","unstructured":"H\u00fcllemann P, Keller T, Kabelitz M, et al. Clinical manifestation of acute, subacute, and chronic low back pain in different age groups: low back pain in 35,446 patients. Pain Pract. 2018;18:1011\u201323. https:\/\/doi.org\/10.1111\/papr.12704.","journal-title":"Pain Pract"},{"key":"886_CR25","doi-asserted-by":"publisher","unstructured":"Mahn F, H\u00fcllemann P, Gockel U, et al. Sensory symptom profiles and co-morbidities in painful radiculopathy. PLOS One. 2011;6:e18018. https:\/\/doi.org\/10.1371\/journal.pone.0018018.","DOI":"10.1371\/journal.pone.0018018"},{"key":"886_CR26","doi-asserted-by":"publisher","first-page":"E786","DOI":"10.1503\/cmaj.171333","volume":"190","author":"O Enke","year":"2018","unstructured":"Enke O, New HA, New CH, et al. Anticonvulsants in the treatment of low back pain and lumbar radicular pain: a systematic review and meta-analysis. CMAJ. 2018;190:E786\u201393. https:\/\/doi.org\/10.1503\/cmaj.171333.","journal-title":"CMAJ"},{"key":"886_CR27","doi-asserted-by":"publisher","unstructured":"Kaki AM, El-Yaski AZ, Youseif E. Identifying neuropathic pain among patients with chronic low-back pain: use of the Leeds Assessment of Neuropathic Symptoms and Signs pain scale. Reg Anesth Pain Med. 2005;30:1\u2013422. https:\/\/doi.org\/10.1016\/j.rapm.2005.05.013.","DOI":"10.1016\/j.rapm.2005.05.013"},{"key":"886_CR28","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1185\/030079906X132488","volume":"22","author":"R Freynhagen","year":"2006","unstructured":"Freynhagen R, Baron R, Gockel U, T\u00f6lle TR. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin. 2006;22:1911\u201320. https:\/\/doi.org\/10.1185\/030079906X132488.","journal-title":"Curr Med Res Opin"},{"key":"886_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068273","volume":"8","author":"M F\u00f6rster","year":"2013","unstructured":"F\u00f6rster M, Mahn F, Gockel U, et al. Axial low back pain: one painful area\u2014Many perceptions and mechanisms. PLoS ONE. 2013;8:e68273. https:\/\/doi.org\/10.1371\/journal.pone.0068273.","journal-title":"PLoS ONE"},{"key":"886_CR30","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/5079675","author":"S Orita","year":"2016","unstructured":"Orita S, Yamashita M, Eguchi Y, et al. Pregabalin for refractory radicular leg pain due to lumbar spinal stenosis: a preliminary prospective study. Pain Res Manag. 2016. https:\/\/doi.org\/10.1155\/2016\/5079675.","journal-title":"Pain Res Manag"},{"key":"886_CR31","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1056\/NEJMoa1614292","volume":"376","author":"S Mathieson","year":"2017","unstructured":"Mathieson S, Maher C, Mclachlan A, et al. Trial of pregabalin for acute and chronic sciatica. N Engl J Med. 2017;376:1111\u201320. https:\/\/doi.org\/10.1056\/NEJMoa1614292.","journal-title":"N Engl J Med"},{"key":"886_CR32","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s10195-009-0077-z","volume":"10","author":"CL Roman\u00f2","year":"2009","unstructured":"Roman\u00f2 CL, Roman\u00f2 D, Bonora C, Mineo G. Pregabalin, celecoxib, and their combination for treatment of chronic low-back pain. J Orthop Traumatol. 2009;10:185\u201391. https:\/\/doi.org\/10.1007\/s10195-009-0077-z.","journal-title":"J Orthop Traumatol"},{"key":"886_CR33","doi-asserted-by":"publisher","first-page":"517","DOI":"10.2165\/11536280-000000000-00000","volume":"30","author":"C Morera-Dom\u00ednguez","year":"2010","unstructured":"Morera-Dom\u00ednguez C, Ceberio-Balda F, Fl\u00f3rez-Garc\u00eda M, Masram\u00f3n X, L\u00f3pez-G\u00f3mez V. A cost-consequence analysis of pregabalin versus usual care in the symptomatic treatment of refractory low back pain: sub-analysis of observational trial data from orthopaedic surgery and rehabilitation clinics. Clin Drug Investig. 2010;30:517\u201331. https:\/\/doi.org\/10.2165\/11536280-000000000-00000.","journal-title":"Clin Drug Investig"},{"key":"886_CR34","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1056\/NEJMra1410151","volume":"372","author":"AH Ropper","year":"2015","unstructured":"Ropper AH, Zafonte RD. Sciatica. N Engl J Med. 2015;372:1240\u20138. https:\/\/doi.org\/10.1056\/NEJMra1410151.","journal-title":"N Engl J Med"},{"key":"886_CR35","doi-asserted-by":"publisher","unstructured":"Vroomen PCAJ, de Krom MCTFM, Wilmink JT, Kester ADM, Knottnerus JA. Diagnostic value of history and physical examination in patients suspected of lumbosacral nerve root compression. J Neurol Neurosurg Psychiat. 2002;72:630\u20134. https:\/\/doi.org\/10.1136\/jnnp.72.5.630.","DOI":"10.1136\/jnnp.72.5.630"},{"key":"886_CR36","unstructured":"Hall H, McIntosh G. Low back pain (acute). Clin Evidence. 2008;2008."},{"key":"886_CR37","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1056\/NEJMe1701147","volume":"376","author":"N Attal","year":"2017","unstructured":"Attal N, Barrot M. Is pregabalin ineffective in acute or chronic sciatica? N Engl J Med. 2017;376:1169\u201370. https:\/\/doi.org\/10.1056\/NEJMe1701147.","journal-title":"N Engl J Med"},{"key":"886_CR38","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1097\/j.pain.0000000000000554","volume":"157","author":"JH Atkinson","year":"2016","unstructured":"Atkinson JH, Slater MA, Capparelli EV, et al. A randomized controlled trial of gabapentin for chronic low back pain with and without a radiating component. Pain. 2016;157:1499\u2013507. https:\/\/doi.org\/10.1097\/j.pain.0000000000000554.","journal-title":"Pain"},{"key":"886_CR39","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.9985","volume":"12","author":"D Kataria","year":"2020","unstructured":"Kataria D, Jumani L, Ahmed MU, Kumar V, Makda A. Comparison of pregabalin versus placebo in reduction of pain due to lumber disc herniation. Cureus. 2020;12:e9985. https:\/\/doi.org\/10.7759\/cureus.9985.","journal-title":"Cureus"},{"key":"886_CR40","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3233\/BMR-2009-0210","volume":"22","author":"K Yildirim","year":"2009","unstructured":"Yildirim K, Deniz O, Gureser G, et al. Gabapentin monotherapy in patients with chronic radiculopathy: the efficacy and impact on life quality. J Back Musculoskelet Rehabil. 2009;22:17\u201320. https:\/\/doi.org\/10.3233\/BMR-2009-0210.","journal-title":"J Back Musculoskelet Rehabil"},{"key":"886_CR41","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1097\/j.pain.0000000000000492","volume":"157","author":"NB Finnerup","year":"2016","unstructured":"Finnerup NB, Haroutounian S, Kamerman P, et al. Neuropathic pain: an updated grading system for research and clinical practice. Pain. 2016;157:1599\u2013606. https:\/\/doi.org\/10.1097\/j.pain.0000000000000492.","journal-title":"Pain"},{"key":"886_CR42","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/S0140-6736(22)01472-6","volume":"400","author":"S Tesfaye","year":"2022","unstructured":"Tesfaye S, Sloan G, Petrie J, et al. Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial. The Lancet Elsevier. 2022;400:680\u201390. https:\/\/doi.org\/10.1016\/S0140-6736(22)01472-6.","journal-title":"The Lancet Elsevier"},{"key":"886_CR43","doi-asserted-by":"publisher","unstructured":"Treweek S, Pitkethly M, Cook J, et al. Strategies to improve recruitment to randomised trials - Treweek, S - 2018 | Cochrane Library. [cited 2026 July 14]; https:\/\/www.cochranelibrary.com\/cdsr\/doi\/https:\/\/doi.org\/10.1002\/14651858.MR000013.pub6\/information. Accessed 14 July 2026.","DOI":"10.1002\/14651858.MR000013.pub6\/information"},{"key":"886_CR44","doi-asserted-by":"publisher","unstructured":"Gallagher RM. Naturalistic study designs in samples with refractory pain: advantages and limitations. Pain Med. Malden, Mass.; 2004;5:143\u20135. https:\/\/doi.org\/10.1111\/j.1526-4637.2004.04036.x","DOI":"10.1111\/j.1526-4637.2004.04036.x"},{"key":"886_CR45","unstructured":"ScienceInsights: what are the limitations of an open label study? [Internet]. [cited 2026 July 14]. https:\/\/scienceinsights.org\/what-are-the-limitations-of-an-open-label-study\/. Accessed 14 July 2026."},{"key":"886_CR46","first-page":"59","volume":"28","author":"H Nagami","year":"2012","unstructured":"Nagami H, Matsui Y. Efficacy of combination therapy with pregabalin in addition to NSAIDs in the treatment of chronic low-back pain. Shimane J Med Sci. 2012;28:59\u201368.","journal-title":"Shimane J Med Sci"},{"key":"886_CR47","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s40261-013-0116-7","volume":"33","author":"E Blanco Tarrio","year":"2013","unstructured":"Blanco Tarrio E, G\u00e1lvez Mateos R, Zamorano Bayarri E, L\u00f3pez G\u00f3mez V, P\u00e9rez P\u00e1ramo M. Effectiveness of pregabalin as monotherapy or combination therapy for neuropathic pain in patients unresponsive to previous treatments in a Spanish primary care setting. Clin Drug Investig. 2013;33:633\u201345. https:\/\/doi.org\/10.1007\/s40261-013-0116-7.","journal-title":"Clin Drug Investig"},{"key":"886_CR48","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2147\/JPR.S88642","volume":"8","author":"T Taguchi","year":"2015","unstructured":"Taguchi T, Igarashi A, Watt S, et al. Effectiveness of pregabalin for the treatment of chronic low back pain with accompanying lower limb pain (neuropathic component): a non-interventional study in Japan. J Pain Res. 2015;8:487\u201397. https:\/\/doi.org\/10.2147\/JPR.S88642.","journal-title":"J Pain Res"},{"key":"886_CR49","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s00296-009-1086-1","volume":"30","author":"MT Salda\u00f1a","year":"2010","unstructured":"Salda\u00f1a MT, Navarro A, P\u00e9rez C, Masram\u00f3n X, Rejas J. Patient-reported-outcomes in subjects with painful lumbar or cervical radiculopathy treated with pregabalin: evidence from medical practice in primary care settings. Rheumatol Int. 2010;30:1005\u201315. https:\/\/doi.org\/10.1007\/s00296-009-1086-1.","journal-title":"Rheumatol Int"},{"key":"886_CR50","doi-asserted-by":"crossref","unstructured":"Toelle T, Varvara R, Nimour M, Emir B, Brasser M. Pregabalin in neuropathic pain related to DPN, cancer and back pain: analysis of a 6-week observational study. Open Pain J. 2012;5.","DOI":"10.2174\/1876386301205010001"},{"key":"886_CR51","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5455\/msm.2023.35.42-47","volume":"35","author":"B Prnjavorac","year":"2023","unstructured":"Prnjavorac B, Kunic S, Pejanovic-Skobic N, et al. Pregabalin in the treatment of peripheral and central chronic neuropathic pain. Mater Sociomed. 2023;35:42\u20137. https:\/\/doi.org\/10.5455\/msm.2023.35.42-47.","journal-title":"Mater Sociomed"},{"key":"886_CR52","doi-asserted-by":"publisher","unstructured":"Yeole AB, Sree Ranga Lakshmi G, Selvakumar CJ, et al. Efficacy and safety of pregabalin prolonged release\u2013etoricoxib combination compared to etoricoxib for chronic low back pain: phase\u00a03, randomized study. Pain Ther. 2022;11:1451\u201369. https:\/\/doi.org\/10.1007\/s40122-022-00437-2.","DOI":"10.1007\/s40122-022-00437-2"},{"key":"886_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00325481.2020.1857992","volume":"133","author":"R Freynhagen","year":"2021","unstructured":"Freynhagen R, Baron R, Kawaguchi Y, et al. Pregabalin for neuropathic pain in primary care settings: recommendations for dosing and titration. Postgrad Med. 2021;133:1\u20139. https:\/\/doi.org\/10.1080\/00325481.2020.1857992.","journal-title":"Postgrad Med"},{"key":"886_CR54","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.pain.2005.02.032","volume":"115","author":"R Freynhagen","year":"2005","unstructured":"Freynhagen R, Strojek K, Griesing T, Whalen E, Balkenohl M. Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain. 2005;115:254\u201363. https:\/\/doi.org\/10.1016\/j.pain.2005.02.032.","journal-title":"Pain"},{"key":"886_CR55","first-page":"31","volume":"65","author":"MB Khosravi","year":"2014","unstructured":"Khosravi MB, Azemati S, Sahmeddini MA. Gabapentin versus naproxen in the management of failed back surgery syndrome; a randomized controlled trial. Acta Anaesthesiol Belg. 2014;65:31\u20137.","journal-title":"Acta Anaesthesiol Belg"},{"key":"886_CR56","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.pain.2010.04.013","volume":"150","author":"R Baron","year":"2010","unstructured":"Baron R, Freynhagen R, T\u00f6lle TR, et al. The efficacy and safety of pregabalin in the treatment of neuropathic pain associated with chronic lumbosacral radiculopathy. Pain. 2010;150:420\u20137. https:\/\/doi.org\/10.1016\/j.pain.2010.04.013.","journal-title":"Pain"},{"key":"886_CR57","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1185\/03007995.2012.674499","volume":"28","author":"G Varrassi","year":"2012","unstructured":"Varrassi G, M\u00fcller-Schwefe G. The international CHANGE PAIN physician survey: does specialism influence the perception of pain and its treatment? Curr Med Res Opin. 2012;28:823\u201331. https:\/\/doi.org\/10.1185\/03007995.2012.674499.","journal-title":"Curr Med Res Opin"},{"key":"886_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpain.2018.06.005","volume":"20","author":"S Mathieson","year":"2019","unstructured":"Mathieson S, Kasch R, Maher CG, et al. Combination drug therapy for the management of low back pain and sciatica: systematic review and meta-analysis. J Pain. 2019;20:1\u201315. https:\/\/doi.org\/10.1016\/j.jpain.2018.06.005.","journal-title":"J Pain"},{"key":"886_CR59","doi-asserted-by":"publisher","first-page":"23","DOI":"10.2217\/pmt.11.71","volume":"2","author":"V Pota","year":"2012","unstructured":"Pota V, Barbarisi M, Sansone P, et al. Combination therapy with transdermal buprenorphine and pregabalin for chronic low back pain. Pain Manag. 2012;2:23\u201331. https:\/\/doi.org\/10.2217\/pmt.11.71.","journal-title":"Pain Manag"},{"key":"886_CR60","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/papr.12200","volume":"15","author":"R Baron","year":"2015","unstructured":"Baron R, Martin-Mola E, M\u00fcller M, Dubois C, Falke D, Steigerwald I. Effectiveness and safety of tapentadol prolonged release (PR) versus a combination of tapentadol PR and pregabalin for the management of severe, chronic low back pain with a neuropathic component: a randomized, double-blind, phase 3b study. Pain Pract. 2015;15:455\u201370. https:\/\/doi.org\/10.1111\/papr.12200.","journal-title":"Pain Pract"},{"key":"886_CR61","doi-asserted-by":"publisher","unstructured":"Farrar JT, Berlin JA, Strom BL. Clinically important changes in acute pain outcome measures: a validation study. J Pain Symp Manag. 2003;25:406\u201311. https:\/\/doi.org\/10.1016\/S0885-3924(03)00162-3","DOI":"10.1016\/S0885-3924(03)00162-3"},{"key":"886_CR62","doi-asserted-by":"publisher","first-page":"257","DOI":"10.2147\/JPR.S78303","volume":"8","author":"R Freeman","year":"2015","unstructured":"Freeman R, Emir B, Parsons B. Predictors of placebo response in peripheral neuropathic pain: insights from pregabalin clinical trials. J Pain Res. 2015;8:257\u201368. https:\/\/doi.org\/10.2147\/JPR.S78303.","journal-title":"J Pain Res"},{"key":"886_CR63","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.euroneuro.2008.08.009","volume":"19","author":"GI Papakostas","year":"2009","unstructured":"Papakostas GI, Fava M. Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD. Eur Neuropsychopharmacol. 2009;19:34\u201340. https:\/\/doi.org\/10.1016\/j.euroneuro.2008.08.009.","journal-title":"Eur Neuropsychopharmacol"},{"key":"886_CR64","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1111\/j.1365-2982.2005.00650.x","volume":"17","author":"SM Patel","year":"2005","unstructured":"Patel SM, Stason WB, Legedza A, et al. The placebo effect in irritable bowel syndrome trials: a meta-analysis. Neurogastroenterol Motil. 2005;17:332\u201340. https:\/\/doi.org\/10.1111\/j.1365-2982.2005.00650.x.","journal-title":"Neurogastroenterol Motil"},{"key":"886_CR65","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00228-005-0088-5","volume":"62","author":"A Macedo","year":"2006","unstructured":"Macedo A, Farr\u00e9 M, Ba\u00f1os J-E. A meta-analysis of the placebo response in acute migraine and how this response may be influenced by some of the characteristics of clinical trials. Eur J Clin Pharmacol. 2006;62:161\u201372. https:\/\/doi.org\/10.1007\/s00228-005-0088-5.","journal-title":"Eur J Clin Pharmacol"},{"key":"886_CR66","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1056\/NEJMc1705241","volume":"376","author":"K Kosugi","year":"2017","unstructured":"Kosugi K, Tagami K, Tanimoto T. Trial of pregabalin for acute and chronic sciatica. N Engl J Med. 2017;376:2396. https:\/\/doi.org\/10.1056\/NEJMc1705241.","journal-title":"N Engl J Med"},{"key":"886_CR67","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1212\/WNL.0000000000002000","volume":"85","author":"JD Markman","year":"2015","unstructured":"Markman JD, Gewandter JS, Frazer ME, et al. Evaluation of outcome measures for neurogenic claudication: a patient-centered approach. Neurology. 2015;85:1250\u20136. https:\/\/doi.org\/10.1212\/WNL.0000000000002000.","journal-title":"Neurology"},{"key":"886_CR68","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1097\/j.pain.0000000000003307","volume":"165","author":"R Freynhagen","year":"2024","unstructured":"Freynhagen R, Fullen BM, Reneman MF, Treede R-D. Functioning in chronic pain: a call for a global definition. Pain. 2024;165:2235\u20139. https:\/\/doi.org\/10.1097\/j.pain.0000000000003307.","journal-title":"Pain"},{"key":"886_CR69","doi-asserted-by":"publisher","unstructured":"Otto JC, Gierthm\u00fchlen J, Kirchhofer V, Borzikowsky C, Baron R. Validation of the questionnaire for symptom assessment in pain disorders for back pain patients (Q-SAP). Eur J Pain. London, England; 2021;25:513\u201328. https:\/\/doi.org\/10.1002\/ejp.1690","DOI":"10.1002\/ejp.1690"},{"key":"886_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102340","volume":"66","author":"G Bova","year":"2023","unstructured":"Bova G, Domenichiello A, Letzen JE, et al. Developing consensus on core outcome sets of domains for acute, the transition from acute to chronic, recurrent\/episodic, and chronic pain: results of the INTEGRATE-pain Delphi process. EClinicalMedicine. 2023;66:102340. https:\/\/doi.org\/10.1016\/j.eclinm.2023.102340.","journal-title":"EClinicalMedicine"},{"key":"886_CR71","unstructured":"Cleeland CS. Measurement of pain by subjective report. Chapman, C R And J D Loeser (Ed ) Advances in pain research and therapy, Vol. 1989;12 issues in pain measurement; workshop, Seattle, Washing: New York, USA, pp. 391\u2013404."},{"key":"886_CR72","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0304-3959(87)91074-8","volume":"30","author":"R Melzack","year":"1987","unstructured":"Melzack R. The short-form McGill pain questionnaire. Pain. 1987;30:191\u20137. https:\/\/doi.org\/10.1016\/0304-3959(87)91074-8.","journal-title":"Pain"},{"key":"886_CR73","doi-asserted-by":"publisher","unstructured":"Roland M, Morris R. A study of the natural history of back pain. Part I: development of a reliable and sensitive measure of disability in low-back pain. Spine (Phila Pa 1976). 1983;8:141\u20134. https:\/\/doi.org\/10.1097\/00007632-198303000-00004.","DOI":"10.1097\/00007632-198303000-00004"},{"key":"886_CR74","first-page":"271","volume":"66","author":"JC Fairbank","year":"1980","unstructured":"Fairbank JC, Couper J, Davies JB, O\u2019Brien JP. The Oswestry low back pain disability questionnaire. Physiotherapy. 1980;66:271\u20133.","journal-title":"Physiotherapy"},{"key":"886_CR75","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/00005650-199603000-00003","volume":"34","author":"JE Ware","year":"1996","unstructured":"Ware JE, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220.","journal-title":"Med Care"},{"key":"886_CR76","doi-asserted-by":"publisher","unstructured":"EuroQol\u2014A new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199\u2013208. https:\/\/doi.org\/10.1016\/0168-8510(90)90421-9","DOI":"10.1016\/0168-8510(90)90421-9"},{"key":"886_CR77","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1477-7525-1-29","volume":"1","author":"RP Snaith","year":"2003","unstructured":"Snaith RP. The hospital anxiety and depression scale. Health Qual Life Outcomes. 2003;1:29. https:\/\/doi.org\/10.1186\/1477-7525-1-29.","journal-title":"Health Qual Life Outcomes"},{"key":"886_CR78","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JBW, L\u00f6we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092\u20137. https:\/\/doi.org\/10.1001\/archinte.166.10.1092.","journal-title":"Arch Intern Med"}],"container-title":["Pain and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-026-00886-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40122-026-00886-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-026-00886-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:53:08Z","timestamp":1794667988000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40122-026-00886-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,12]]},"references-count":78,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["886"],"URL":"https:\/\/doi.org\/10.1007\/s40122-026-00886-z","relation":{},"ISSN":["2193-8237","2193-651X"],"issn-type":[{"value":"2193-8237","type":"print"},{"value":"2193-651X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,12]]},"assertion":[{"value":"8 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ralf Baron has received grants or contracts from EU, BMBF, Pfizer, Gr\u00fcnenthal, Mundipharma, Alnylam, Zambon, Sanofi Aventis and Viatris to his institution and has received consulting fees or honoraria from Pfizer, Sanofi Aventis, Gr\u00fcnenthal, Eli Lilly, AstraZeneca, Teva, AbbVie, Glenmark, Novartis, Biotest, Desitin, Bayer, Lateral, Alnylam, Confo, EVA, Merz, Neumentum, Algo, Nanobiotix, Chiesi, Stada, Viatris, Hexal, Heat2Move, Hoba, BioNTech, Esteve, Aristo, SIMR, Vertanical, SelectION, Max-Delbr\u00fcck-Centrum, Janssen, Amicus, Novo Nordisk, Takeda, Ever, Unilab, Esanum, Docflix, and Denk. Rainer Freynhagen has received consulting, advisory board, or speaking fees from AISSP e.V., Augustin Therapeutics, Gr\u00fcnenthal, Mediverbund AG, Medscape, P&G, Park Therapeutics, Searchlight Pharma, and Viatris. Bart Morlion has received consulting fees or honoraria from Viatris, Opella, Krka, and Haleon and is an unpaid member of the EFIC Pain school committee. Andrea Truini has received consulting fees from Epitech and Angelini to his institution and has received consulting fees from Abbvie, Amgen, Exeltis, Gr\u00fcnenthal, Pharmaline, and Viatris. Sebnem Er is an employee of Viatris. Chris Walker is an employee of Viatris and holds shares in Pfizer Inc. and Viatris. Gavin Lyndon is a paid consultant for Viatris and owns shares in Pfizer Inc. and Viatris.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}